Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice: Comparative protective efficacy of antibodies to tumor necrosis factor-α and to lipopolysaccharide

G. Zanetti, D. Heumann, J. Gerain, J. Kohler, P. Abbet, C. Barras, Rudolf Lucas, M. P. Glauser, J. D. Baumgartner

Research output: Contribution to journalArticle

204 Citations (Scopus)

Abstract

The production of TNF-α, IL-1, and IL-6 was measured in mice after bolus i.v. Escherichia coli O111 LPS injections and during bacteremia induced either by bolus i.v. or by i.p. challenges of live E. coli O111. High but transient TNF-α peaks were observed after bolus i.v. LPS or bacterial challenges. In contrast, the levels during lethal peritonitis increased progressively to values 50- to 100-fold lower than the peak values observed after i.v. injections, and remained sustained until death. Whereas after i.v. challenge with 1000 LD50 of LPS, anti-TNF-α antibody fully protected mice from death and reduced serum IL-1 and IL-6 levels, anti-TNF-α antibody did not improve the survival of mice nor reduced serum IL-1 and IL-6 levels after i.p. bacterial challenge. In contrast to anti-TNF-α antibodies, anti-LPS antibodies were protective in the peritonitis model. Protection was accompanied by a striking reduction of bacterial numbers and of TNF-α, IL-1, and IL-6 levels in the serum, but the levels of these cytokines were only marginally affected in the peritoneal lavage fluid. This latter observation demonstrates that the local peritoneal cytokines did not diffuse readily into the circulation, thus suggesting that at least part of the circulating cytokines are produced systemically. In conclusion, the striking differences between cytokine profiles as well as the divergent efficacy of anti-TNF-α antibody after i.v. bolus and after i.p. challenges suggest that TNF-α may not be as important in the pathogenesis of lethal peritonitis than after lethal acute bacteremia.

Original languageEnglish (US)
Pages (from-to)1890-1897
Number of pages8
JournalJournal of Immunology
Volume148
Issue number6
StatePublished - Jan 1 1992
Externally publishedYes

Fingerprint

Lipopolysaccharides
Anti-Idiotypic Antibodies
Interleukin-1
Tumor Necrosis Factor-alpha
Cytokines
Interleukin-6
Peritonitis
Antibodies
Bacteremia
Serum
Escherichia coli
Peritoneal Lavage
Injections
Ascitic Fluid
Lethal Dose 50
Observation

ASJC Scopus subject areas

  • Immunology

Cite this

Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice : Comparative protective efficacy of antibodies to tumor necrosis factor-α and to lipopolysaccharide. / Zanetti, G.; Heumann, D.; Gerain, J.; Kohler, J.; Abbet, P.; Barras, C.; Lucas, Rudolf; Glauser, M. P.; Baumgartner, J. D.

In: Journal of Immunology, Vol. 148, No. 6, 01.01.1992, p. 1890-1897.

Research output: Contribution to journalArticle

Zanetti, G. ; Heumann, D. ; Gerain, J. ; Kohler, J. ; Abbet, P. ; Barras, C. ; Lucas, Rudolf ; Glauser, M. P. ; Baumgartner, J. D. / Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice : Comparative protective efficacy of antibodies to tumor necrosis factor-α and to lipopolysaccharide. In: Journal of Immunology. 1992 ; Vol. 148, No. 6. pp. 1890-1897.
@article{bff7094a023941e9a6ae454a18d37a95,
title = "Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice: Comparative protective efficacy of antibodies to tumor necrosis factor-α and to lipopolysaccharide",
abstract = "The production of TNF-α, IL-1, and IL-6 was measured in mice after bolus i.v. Escherichia coli O111 LPS injections and during bacteremia induced either by bolus i.v. or by i.p. challenges of live E. coli O111. High but transient TNF-α peaks were observed after bolus i.v. LPS or bacterial challenges. In contrast, the levels during lethal peritonitis increased progressively to values 50- to 100-fold lower than the peak values observed after i.v. injections, and remained sustained until death. Whereas after i.v. challenge with 1000 LD50 of LPS, anti-TNF-α antibody fully protected mice from death and reduced serum IL-1 and IL-6 levels, anti-TNF-α antibody did not improve the survival of mice nor reduced serum IL-1 and IL-6 levels after i.p. bacterial challenge. In contrast to anti-TNF-α antibodies, anti-LPS antibodies were protective in the peritonitis model. Protection was accompanied by a striking reduction of bacterial numbers and of TNF-α, IL-1, and IL-6 levels in the serum, but the levels of these cytokines were only marginally affected in the peritoneal lavage fluid. This latter observation demonstrates that the local peritoneal cytokines did not diffuse readily into the circulation, thus suggesting that at least part of the circulating cytokines are produced systemically. In conclusion, the striking differences between cytokine profiles as well as the divergent efficacy of anti-TNF-α antibody after i.v. bolus and after i.p. challenges suggest that TNF-α may not be as important in the pathogenesis of lethal peritonitis than after lethal acute bacteremia.",
author = "G. Zanetti and D. Heumann and J. Gerain and J. Kohler and P. Abbet and C. Barras and Rudolf Lucas and Glauser, {M. P.} and Baumgartner, {J. D.}",
year = "1992",
month = "1",
day = "1",
language = "English (US)",
volume = "148",
pages = "1890--1897",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "6",

}

TY - JOUR

T1 - Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice

T2 - Comparative protective efficacy of antibodies to tumor necrosis factor-α and to lipopolysaccharide

AU - Zanetti, G.

AU - Heumann, D.

AU - Gerain, J.

AU - Kohler, J.

AU - Abbet, P.

AU - Barras, C.

AU - Lucas, Rudolf

AU - Glauser, M. P.

AU - Baumgartner, J. D.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - The production of TNF-α, IL-1, and IL-6 was measured in mice after bolus i.v. Escherichia coli O111 LPS injections and during bacteremia induced either by bolus i.v. or by i.p. challenges of live E. coli O111. High but transient TNF-α peaks were observed after bolus i.v. LPS or bacterial challenges. In contrast, the levels during lethal peritonitis increased progressively to values 50- to 100-fold lower than the peak values observed after i.v. injections, and remained sustained until death. Whereas after i.v. challenge with 1000 LD50 of LPS, anti-TNF-α antibody fully protected mice from death and reduced serum IL-1 and IL-6 levels, anti-TNF-α antibody did not improve the survival of mice nor reduced serum IL-1 and IL-6 levels after i.p. bacterial challenge. In contrast to anti-TNF-α antibodies, anti-LPS antibodies were protective in the peritonitis model. Protection was accompanied by a striking reduction of bacterial numbers and of TNF-α, IL-1, and IL-6 levels in the serum, but the levels of these cytokines were only marginally affected in the peritoneal lavage fluid. This latter observation demonstrates that the local peritoneal cytokines did not diffuse readily into the circulation, thus suggesting that at least part of the circulating cytokines are produced systemically. In conclusion, the striking differences between cytokine profiles as well as the divergent efficacy of anti-TNF-α antibody after i.v. bolus and after i.p. challenges suggest that TNF-α may not be as important in the pathogenesis of lethal peritonitis than after lethal acute bacteremia.

AB - The production of TNF-α, IL-1, and IL-6 was measured in mice after bolus i.v. Escherichia coli O111 LPS injections and during bacteremia induced either by bolus i.v. or by i.p. challenges of live E. coli O111. High but transient TNF-α peaks were observed after bolus i.v. LPS or bacterial challenges. In contrast, the levels during lethal peritonitis increased progressively to values 50- to 100-fold lower than the peak values observed after i.v. injections, and remained sustained until death. Whereas after i.v. challenge with 1000 LD50 of LPS, anti-TNF-α antibody fully protected mice from death and reduced serum IL-1 and IL-6 levels, anti-TNF-α antibody did not improve the survival of mice nor reduced serum IL-1 and IL-6 levels after i.p. bacterial challenge. In contrast to anti-TNF-α antibodies, anti-LPS antibodies were protective in the peritonitis model. Protection was accompanied by a striking reduction of bacterial numbers and of TNF-α, IL-1, and IL-6 levels in the serum, but the levels of these cytokines were only marginally affected in the peritoneal lavage fluid. This latter observation demonstrates that the local peritoneal cytokines did not diffuse readily into the circulation, thus suggesting that at least part of the circulating cytokines are produced systemically. In conclusion, the striking differences between cytokine profiles as well as the divergent efficacy of anti-TNF-α antibody after i.v. bolus and after i.p. challenges suggest that TNF-α may not be as important in the pathogenesis of lethal peritonitis than after lethal acute bacteremia.

UR - http://www.scopus.com/inward/record.url?scp=0026568118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026568118&partnerID=8YFLogxK

M3 - Article

C2 - 1541827

AN - SCOPUS:0026568118

VL - 148

SP - 1890

EP - 1897

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 6

ER -